Table 4.
CFO | TCO | EFO | |
---|---|---|---|
Lipid content | 3.7 ± 0.3 | 4.3 ± 0.9 | 3.8 ± 1.6 |
14:0 | 2.5 ± 0.1a | 1.5 ± 0.2b | 2.8 ± 0.5a |
16:0 | 16.0 ± 0.6a | 14.5 ± 0.3b | 15.9 ± 0.5a |
18:0 | 4.0 ± 0.5 | 4.3 ± 0.1 | 3.7 ± 0.4 |
Total saturated1 | 23.2 ± 1.0 | 21.4 ± 0.3 | 23.2 ± 0.5 |
16:1n-7 | 3.9 ± 0.1a | 2.6 ± 0.2b | 4.3 ± 0.4a |
18:1n-9 | 31.6 ± 1.0a | 22.1 ± 1.1b | 29.7 ± 2.8a |
18:1n-7 | 2.9 ± 0.0 | 2.2 ± 0.1 | 2.9 ± 0.2 |
20:1n-9 | 1.8 ± 0.0 | 3.5 ± 0.4 | 2.1 ± 0.3 |
22:1n-11 | 1.0 ± 0.1a | 0.8 ± 0.1b | 1.0 ± 0.1a |
Total monoenes2 | 42.8 ± 0.8 | 32.8 ± 1.1 | 41.6 ± 3.2 |
18:2n-6 | 11.3 ± 0.5b | 15.6 ± 0.8a | 11.7 ± 0.7b |
18:3n-6 | 0.2 ± 0.0 | 1.1 ± 0.2 | 0.3 ± 0.1 |
20:2n-6 | 0.4 ± 0.0 | 0.9 ± 0.1 | 0.5 ± 0.1 |
20:3n-6 | 0.1 ± 0.0b | 0.4 ± 0.0a | 0.1 ± 0.1b |
20:4n-6 | 0.7 ± 0.0 | 1.9 ± 0.1 | 0.7 ± 0.3 |
22:5n-6 | 0.2 ± 0.0a | 0.1 ± 0.0b | 0.2 ± 0.0a |
Total n-6 PUFA3 | 13.0 ± 0.5b | 20.3 ± 1.1a | 13.6 ± 1.2b |
18:3n-3 | 3.6 ± 0.2 | 5.6 ± 0.4 | 3.7 ± 0.3 |
18:4n-3 | 0.8 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 |
20:3n-3 | 0.1 ± 0.0b | 0.5 ± 0.1a | 0.1 ± 0.1b |
20:4n-3 | 0.3 ± 0.0b | 1.1 ± 0.1a | 0.4 ± 0.1b |
20:5n-3 | 6.3 ± 0.1 | 6.4 ± 0.2 | 6.7 ± 0.4 |
22:5n-3 | 0.8 ± 0.3b | 2.6 ± 0.2a | 1.2 ± 0.3b |
22:6n-3 | 8.0 ± 0.7 | 7.9 ± 0.4 | 7.1 ± 1.5 |
Total n-3 PUFA4 | 20.1 ± 1.2b | 25.1 ± 0.6a | 20.4 ± 2.4b |
Total n-3 LC-PUFA | 15.7 ± 1.0 | 18.6 ± 0.5 | 15.8 ± 2.3 |
Results are means ± SEM (n = 3). Different superscript letters within a row denote significant differences between diets as determined by one-way ANOVA with Tukey and Duncan's comparison test (P < .05). CFO, commercial fish and vegetable oil feed; EFO, enhanced fish and vegetable oil feed; TCO, transgenic Camelina oil feed.
Total saturated includes 15:0, 20:0, 22:0 and 24:0.
Total monounsaturated includes 16:1n-9,17:1, 20:1n-11, 20:1n-7, 22:1n-9 and 24:1n-9.
Total n-6 PUFA includes 20:3n-6 and 22:4n-6.
Total n-3 PUFA includes 20:3n-3.